Skip to main content Skip to navigation

Press Releases


Select tags to filter on

Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of Warwick

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the University of Warwick.

Mon 17 Jan 2022, 10:14 | Tags: School of Life Sciences, Life Sciences, COVID-19, Virology, Sciences

Exercise during lockdown fell particularly for groups most at risk

A study of UK resident’s exercise patterns during the COVID-19 lockdown in March-June 2020, has found that groups that were most at risk to the adverse effects of COVID-19 were impacted the most in terms of reducing their levels of exercise. Researchers led by WMG, University of Warwick say targeted interventions are required to ensure physical and mental health impacts of sedentary behaviour do not exacerbate the risks to these groups.

Mon 01 Nov 2021, 10:00 | Tags: Health, WMG, COVID-19, Sciences

Alternative to antibodies in diagnostics demonstrated in fight against viral infections such as COVID-19

Researchers at the University of Warwick, Iceni Diagnostics Ltd and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust have demonstrated their technology to detect SARS-COV-2 using sugars rather than antibodies.

Fri 15 Oct 2021, 09:51 | Tags: research, Chemistry, WMS, Warwick Medical School, COVID-19

Has COVID 19 undermined the rule of law? New research examines actions in the Western Balkans

The coronavirus pandemic has presented populist governments with a unique opportunity to implement authoritarian measures and to limit public scrutiny of their decisions and policies, argues Dr Andi Hoxhaj of Warwick Law School in a new paper published in the European Journal of Comparative Law and Governance.


RECOVERY-RS trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients

The Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial, co-led by the University of Warwick, has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.


Older news